Events 02/23/26 Japan-UK Symposium on children and young people's cancer in Tokyo

Outline

The Japan Agency for Medical Research and Development (AMED) promotes cancer research based on the Basic Plan to Promote Cancer Control Programs and the　Comprehensive 10-Year Strategy for Cancer Control, which includes fostering an environment for international collaborative clinical trials. Particularly, children’s and young people’s (CYP) cancers fall under the category of rare cancers, and conducting clinical trials poses significant challenges.
As part of this activity, AMED will jointly host a symposium with the UK National Institute for Health and Care Research (NIHR) on CYP cancers, to encourage collaboration between the UK and Japan in CYP cancer research and to discuss future possibilities for international collaboration.
We warmly welcome the participation of CYP cancer patients, their families and carers, as well as researchers in related fields.
This symposium will be recorded and shared among the registered participants/audience.

On-site: Speakers, moderators and authorised personnels only
Online: General audience
Online participation will be possible via Zoom webinar. The URL will be provided to those who have registered to participate online.

Researchers interested in CYP cancer research and international collaborative research between Japan and the UK.
Pediatric/CYP cancer patients, their families and carers.

Online Participation: 500 people (Registration will close once online capacity has been reached.)

Registration is free

The audience registration site is scheduled to be released and open for registration in January 2026.
※Language：English

Japan Agency for Medical Research and Development (AMED)
National Institute for Health and Care Research (NIHR)

Note: Patient perspectives, Care, Cross-cutting topics, including Genomic medicine, Advanced therapies, and Cell and gene therapies, will be added to each session.